Name | Number of supported studies | Average coverage | |
---|---|---|---|
macrophage | 6 studies | 20% ± 3% | |
monocyte | 6 studies | 24% ± 7% | |
alveolar macrophage | 4 studies | 34% ± 13% | |
endothelial cell | 3 studies | 27% ± 1% | |
hepatocyte | 3 studies | 34% ± 24% | |
type I pneumocyte | 3 studies | 16% ± 1% |
Insufficient scRNA-seq data for expression of FLVCR2 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
kidney | 98% | 574.09 | 87 / 89 | 95% | 9.06 | 855 / 901 |
liver | 100% | 1483.27 | 226 / 226 | 91% | 7.16 | 371 / 406 |
thymus | 99% | 492.93 | 646 / 653 | 91% | 6.40 | 553 / 605 |
lung | 99% | 1129.25 | 574 / 578 | 85% | 6.58 | 981 / 1155 |
breast | 87% | 355.68 | 401 / 459 | 80% | 3.72 | 893 / 1118 |
bladder | 86% | 227.48 | 18 / 21 | 72% | 4.01 | 364 / 504 |
skin | 88% | 569.10 | 1588 / 1809 | 64% | 2.89 | 302 / 472 |
intestine | 83% | 847.87 | 803 / 966 | 67% | 3.06 | 355 / 527 |
adrenal gland | 100% | 1808.63 | 258 / 258 | 36% | 3.13 | 82 / 230 |
esophagus | 65% | 200.07 | 937 / 1445 | 70% | 3.77 | 128 / 183 |
prostate | 91% | 353.80 | 222 / 245 | 43% | 1.35 | 218 / 502 |
ovary | 78% | 291.47 | 140 / 180 | 46% | 1.55 | 196 / 430 |
brain | 19% | 61.44 | 504 / 2642 | 93% | 7.55 | 655 / 705 |
uterus | 49% | 118.76 | 84 / 170 | 62% | 3.13 | 284 / 459 |
spleen | 100% | 2119.83 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.21 | 1 / 1 |
lymph node | 0% | 0 | 0 / 0 | 93% | 9.16 | 27 / 29 |
adipose | 89% | 421.44 | 1068 / 1204 | 0% | 0 | 0 / 0 |
stomach | 23% | 57.57 | 82 / 359 | 65% | 2.87 | 185 / 286 |
peripheral blood | 87% | 603.91 | 809 / 929 | 0% | 0 | 0 / 0 |
muscle | 84% | 640.76 | 672 / 803 | 0% | 0 | 0 / 0 |
pancreas | 4% | 10.46 | 12 / 328 | 80% | 4.14 | 142 / 178 |
tonsil | 0% | 0 | 0 / 0 | 80% | 4.08 | 36 / 45 |
heart | 46% | 129.16 | 392 / 861 | 0% | 0 | 0 / 0 |
blood vessel | 34% | 129.48 | 460 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 30% | 0.82 | 24 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0097037 | Biological process | heme export |
GO_0055085 | Biological process | transmembrane transport |
GO_0031966 | Cellular component | mitochondrial membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_0015232 | Molecular function | heme transmembrane transporter activity |
GO_0020037 | Molecular function | heme binding |
Gene name | FLVCR2 |
Protein name | Heme transporter FLVCR2 (Calcium-chelate transporter) (CCT) (Feline leukemia virus subgroup C receptor-related protein 2) FLVCR heme transporter 2 |
Synonyms | C14orf58 |
Description | FUNCTION: Putative heme b importer/sensor involved in heme homeostasis in response to the metabolic state of the cell and to diet. May act as a sensor of cytosolic and/or mitochondrial heme levels to regulate mitochondrial respiration processes, ATP synthesis and thermogenesis. At low heme levels, interacts with components of electron transfer chain (ETC) complexes and ATP2A2, leading to ubiquitin-mediated degradation of ATP2A2 and inhibition of thermogenesis. Upon heme binding, dissociates from ETC complexes to allow switching from mitochondrial ATP synthesis to thermogenesis. Alternatively, in coordination with ATP2A2 may mediate calcium transport and signaling in response to heme. . |
Accessions | G3V5P5 ENST00000553341.5 ENST00000555027.1 ENST00000553587.5 G3V5Q8 Q9UPI3 ENST00000556856.1 G3V5Y3 G3V391 G3V4G2 ENST00000539311.5 [Q9UPI3-2] ENST00000554580.5 ENST00000238667.9 [Q9UPI3-1] G3V458 ENST00000555058.5 |